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Abstract.  Sequences within the first intron of the 
od(I) collagen gene have been implicated in the regu- 
lation of expression of .l(I) collagen-reporter gene 
constructs in cultured cells. However, the physiological 
significance of these intronic elements has not been es- 
tablished. We have used in situ hybridization to exam- 
ine whether a cell-specific pattern of expression of hu- 
man oel  (I) collagen-human growth hormone minigenes 
exists in transgenic mice. Our results indicate that 
transgenes which contained 2,300 bp of promoter/5' 
flanking sequence and an intact first intron were well 
expressed by fibroblasts in dermis and fascia, whereas 
transgenes lacking the intronic sequence,  +292 to 
+1440,  were not expressed in dermis and poorly ex- 
pressed in fascia. Analysis of transgene expression in 
cultured fibroblasts obtained from dermal explants of 
transgenic animals confirmed the requirement for these 
intronic sequences in the regulation of the .l(1) colla- 
gen gene. In contrast, transgenes with or without the 
intronic deletion were expressed equally well in ten- 
don and bone, in a manner comparable to the endoge- 
nous mouse od(I) collagen gene, and expression of 
neither transgene was detected in skeletal muscle or 
perichondrium. These data support a model in which 
cis-acting elements in the first intron, and their cog- 
nate DNA-binding proteins, mediate transcription of 
the al(I) collagen gene in some cells, such as dermal 
fibroblasts,  but not in tendon cells or osteoblasts. 
Moreover, regions of the gene not included in the se- 
quence,  -2300 to  +1440, appear to be required for 
transcription in tissues such as skeletal muscle and 
perichondrium. 
T 
YPE I collagen,  a major fibrillar extracellular matrix 
protein,  is necessary for the structural integrity of 
vertebrate tissues. The synthesis of type I collagen is 
modulated in numerous biological  processes that include 
wound healing, tissue morphogenesis, and fibrosis (reviewed 
in  Adams,  1989; Bomstein  and  Sage,  1989; de  Crom- 
brugghe et al., 1991). Correct expression of type I collagen 
requires the cell-specific, coordinated expression of the two 
genes that encode  the type I collagen polypeptides, otl (I) and 
oe2(I). Each gene is present as a single copy and is tran- 
scribed in a number of different cell types, e.g., fibroblasts 
in fascia, dermis and tendon, osteoblasts, odontoblasts,  and 
skeletal  and smooth muscle ceils  (Sandberg  and Vuorio, 
1987; Cheah et al., 1991; Niederreither  et al., 1992). Several 
extracellular  signaling  molecules,  such  as  TGF-B, IL-1, 
TNFc~, and vitamins D  and C, modulate the synthesis of 
type I collagen during normal and pathological  conditions 
(Adams, 1989; Slack et al., 1993). Although both transcrip- 
tional  and posttranscriptional  mechanisms are involved in 
the regulation of type I  collagen  synthesis  in response to 
these diverse stimuli, the predominant mode of control ap- 
pears to be transcriptional  (Penttinen et al., 1988; Harrison 
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et al., 1990; de Crombrugghe et al., 1991; Diaz et al., 1993; 
Slack et'.al.,  1993). 
Experiments designed to identify cell-specific, cis-acting 
elements in the od(1) collagen gene have indicated that the 
gene is regulated in a complex manner. The basal promoter 
(,~,400 bp) of  the .l(I) collagen gene contains binding activi- 
ties for a number of  trans-acting factors that include the same 
CAAT-binding factor as that utilized by the ,2(I) collagen 
gene (Brenner et al., 1989; Karsenty and de Crombrugghe, 
1990). However, the ability of the basal promoter to direct 
tissue- or cell-specific expression of reporter genes remains 
controversial  (Bomstein and McKay,  1988; Rippe  et al., 
1989; Boast et al., 1990). In addition, cis-acting DNA ele- 
ments have been identified both 5' to the basal promoter and 
within the first intron of the od(I) collagen gene (Bomstein 
et al.,  1988; Rippe et al.,  1989; Boast et al.,  1990; Liska 
et al., 1990, 1992). Two orientation-dependent  intronic ele- 
ments  have  been  characterized further by  DNA-binding 
assays  and by site-directed  mutagenesis:  an APl-binding 
sequence that enhances transcription  (Liska et al.,  1990; 
MHttii et al., 1993), and two tandem SPl-binding sequences 
that have a modest inhibitory effect on transcription  (Liska 
et al., 1992). Although these sequences appear to be func- 
tional  in primary cultured fibroblasts  and in some fibro- 
blast cell lines,  several studies have shown that these cis- 
acting sequences are not functional in other cell lines, such 
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Boast et al.,  1990; Olsen et al.,  1990). One hypothesis that 
could account for these  disparate  observations  is  that  se- 
quences within the first intron mediate expression of  the od(I) 
collagen gene in a  cell type-specific manner. 
Another model that emphasizes the complexity of regula- 
tion of the cd(I) collagen gene is the Movl3 mouse, in which 
the Moloney murine leukemia virus has been integrated into 
the first intron of the gene. In Movl 3 mice, the ,1(I) collagen 
gene is transcriptionally inactive in fibroblasts and in most 
other mesenchymal cells, with the exception of osteoblasts 
and odontoblasts (Schnieke et al.,  1983; Kratochwil et al., 
1989; Schwarz et al., 1990). The block in transcriptional ac- 
tivation is associated with the absence of a DNase I-hyper- 
sensitive (DNase HS) 1 site; this finding suggests that thein- 
hibition results from an alteration in chromatin conformation 
at the cd(I) collagen gene locus (Breindl et al.,  1984). It has 
been speculated that the transcriptional block is caused by 
proviral  disruption  of interactions  between  cis-acting ele- 
ments that reside upstream and downstream from the initia- 
tion site of the od(I) collagen gene (Harbers  et al.,  1984; 
Breindl et al., 1984). l~tken together, these observations sug- 
gest  that  fibroblasts  require  intronic  and/or  other  3'  se- 
quences to be present in a  spatially correct manner for ex- 
pression of the ~1(I) collagen gene, whereas osteoblasts rely 
on 5' sequences  for expression  of the gene.  In support of 
these  considerations,  chloramphenicol  acetyl  transferase 
(CAT) reporter constructs containing only 5'-flanking od(I) 
collagen as a promoter DNA are strongly expressed in cul- 
tured osteoblast cell lines and in bone and tendon of trans- 
genie animals (Pavlin et al.,  1992; Krebsbach et al.,  1993). 
To investigate the regulation of the od(I) collagen gene in 
vivo, we prepared a series of transgenic animals with human 
~l(I)COL-human  growth  hormone  (hGH)  minigenes,  in 
which  the  collagen  transgene  includes  or  lacks  putative 
regulatory  sequences  within  the  first intron  (Slack et al., 
1991). We found that transgenes driven by 2,300 bp of od(I) 
collagen 5'-flanking sequence,  with or without the first in- 
tron, were expressed in a tissue-specific manner and, in most 
tissues, at levels approaching that of the endogenous mouse 
gene. In contrast, several fines of mice that contained only 
444 bp of od(I) Y-flanking sequence, with or without the first 
intron,  exhibited a  level of expression in most tissues that 
was 15- to 500-fold lower than that observed with the longer 
promoter.  Although  transgenes  that  contained  a  444-bp 
promoter and the first intron retained  a  modest degree of 
tissue-specific  expression,  those  without  the  first  intron 
lacked tissue specificity and were poorly expressed in all tis- 
sues examined. 
Thus,  our  analysis  of the  tissue-specific  expression  of 
the cd(I)COL-hGH transgenes  showed that Y-flanking se- 
quences are necessary for full expression of the od(I) colla- 
gen gene in most tissues and suggested that, under some con- 
ditions, intronic sequences are also important. However, this 
analysis did not clarify the role of the first intron in the ex- 
pression of the od(I) collagen gene, nor did it assess the cell 
type-specific regulation  of expression by the various od(I) 
collagen DNA sequences.  To define further the role of in- 
1. Abbreviations used in this paper: CAT, chloramphenicol  acetyltransfer- 
ase; DNase HS, DNase I-hypersensitive; hGH, human growth hormone; 
mCOL, mouse endogenous ¢(I) collagen; 3' UTR, 3' untranslated region. 
tronic  sequences,  we  have  extended  our  studies  of these 
transgenic  animals to investigate  the cell type-specific ex- 
pression of the transgenes in the presence and absence of se- 
quences  within  the  first  intron.  We  found that transgenic 
animals carrying constructs with 2,300 bp of 5'-flanking se- 
quence and the first intron expressed the transgene in dermal 
fibroblasts  and  in  many other  collagen-synthesizing cells. 
However, transgenes in which putative regulatory sequences 
in the first intron had been deleted were expressed poorly, 
or not at all,  in dermal fibroblasts but continued to be ex- 
pressed in cells such as osteoblasts and tendon cells. These 
data verify that sequences within the first intron are neces- 
sary  for  expression  of the  ~1(I)  collagen  gene  in  dermal 
fibroblasts in vitro. Our results also support a model in which 
intronic,  cis-aodng  sequences  regulate  expression  of the 
~1(I) collagen gene in fibroblasts by an interaction between 
cis-acting elements in the promoter and first intron mediated 
by DNA-binding proteins, and/or by alteration of the chro- 
matin conformation at the ~1(I) collagen gene locus. 
Materials and Methods 
Transgenic Mice 
The generation of transgenic mouse lines has been previously described 
(Slack et ai., 1991). Transgenic mouse lines were maintained by outhreed- 
ing with C57BL/6 mice. Animals  positive for the transgene were identified 
by dot-blot analysis of tail DNA with a random prime-labeled BamHI- 
HindlII hGH fragment  from the pUC-hGH  cassette (Bornstein and McKay, 
1988). Day I of pregnancy was determined by the presence of a vaginal 
plug. Pregnant females were killed on the 17  th d of gestation by cervical 
dislocation, the uterus was removed, and embryos were rapidly dissected 
in phosphate-buffered saline. Embryos positive for the transgene were 
identified by det-blot analysis of DNA obtained from the head of the em- 
bryo. Explants  of  skin for cell culture and tissue samples for RNA extraction 
were snap-frozen  in dry ice-ethanol  and were stored at -70°C until embryos 
positive for the transgene were identified. For in situ hybridization, embryos 
were severed at the midiine, fixed in 4% paraformaldehyde  for 24 h, and 
stored in 70% ethanol at 4°C until embryos  positive for the transgene were 
identified. 
Cell Culture of Dermal l~broblasts 
Full-thickness sections  of  skin were  dissected from the anima!s, cut into 0.5- 
cm  2 pieces, and incubated for 1 h in DME with 20% calf serum and 10x 
antibiotics (25 mg/mi amphotericin, 1,000 u/ml streptomycin, and 1,000 
u/nil penicillin G). Sections  were subsequently  incubated with 3 mg/mi  col- 
lagenase (Worthington  Biochemical  Corp., Freehold, NJ) and 0.075 mg/ml 
trypsin in serum-free  DME containing 10× antibiotics for 1 h at 37°C. Sec- 
tions were separated from the enzyme mixture by. centrifugation, rinsed, 
and plated onto a petri dish with the dermis side down. A small amount 
of medium (DME, 20% calf serum, 10x antibiotics) was added to cover 
the entire surface  of  the explant. Media were changed  daily until ,o100-200 
fibroblasts migrated from  the edge of the explant. The explant was gently 
removed and the fibroblasts were propagated in DME containing 15 % calf 
serum and lx antibiotics. Fibroblasts were cultured a maximum of three 
passages, at a  split ratio of 1:3, before analysis. 
Analysis of  RNA Levels 
Preparation of RNA from cultured cells or tissue samples, and subsequent 
quantification of hGH and endogenous mouse al(D  collagen (mCOL) 
mRNA by RNase protection analysis, have been described (Liska et al., 
1990, 1992; Slack et al.,  1991). RNA concentrations were determined by 
measurement at 260 urn. A riboprobe  corresponding  to exon 5 of the hGH 
minigene was used to detect the transgene; no protected bands were seen 
after hybridization  of  the hGH riboprobe to RNA from nontransgenic  mice 
(Slack et al.,  1991). We used a riboprobe specific for a 310-bp fragment 
containing sequences from the 3' untranslated region (3' UTR) of mCOL 
for detection of expressed mCOL (Slack et ai.,  1991; Reed et al.,  1993). 
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Paraformaldehyde-fixed  embryos were embedded in paraffin  and cut into 
5-tan sections. The sections were dewaxed as described (Reed et al., 1993) 
and were prehybridized in hybridization buffer (0.6 M NaC1, 0.12 M Tris- 
(21, pH 8.0, 0.008 M EDTA, 0.02% Ficol1400,  0.02% polyvinylpyrrolidone, 
0.1% Pentex BSA, 500 #8/ml salmon sperm DNA, 600 #g/ml yeast tRNA, 
and 50% deionized formamide) overnight  at 50"C in an humidified chamber 
with filter paper saturated with 4x SSC and 50% formamide.  Sections were 
hybridized with asS-labeled hGH or mCOL riboprobes (6  x  IO  s cpm per 
slide) overnight at 50"C in hybridization buffer that contained 10% dextran 
sulfate, 0.1% SDS, and 10 ram DTT. The sections were washed,  incubated 
with RNase A (40 #g/ml; Sigma Chemical Co., St. Louis, MO) and RNase 
T1 (Sigma Chemical Co.), washed at high stringency  (0.Ix SSC for 2 h at 
65°C) to assure low background, and dehydrated with a series of ethanol/0.3 
M  ammonium acetate  solutions.  Slides  were  coated with NTB2 nuclear 
emulsion (Eastman Kodak Co., Rochester, NY), exposed for 10-14 d at 4°C 
in light-excluded chambers, developed in Kodak D-19 developer, and fixed 
in GBX fixer. Sections were counterstained with methyl green, dehydrated 
with ethanol, cleared in xylene, and mounted with Permouut. Sections were 
photographed  on  a  Zeiss  photomieroscope  equipped  with  bright  and 
darldield condensers (Carl Zeiss,  Inc., Thornwood,  NY). 
Results 
Cell-specific Expression of the -2300COL-hGH 
Minigene in Transgenic Animals 
To understand the regulation of expression of the al(I) colla- 
gen gene, we had previously prepared transgenic animals 
carrying varying sequences of the human el(I) collagen pro- 
rooter and first intron driving an hGH mim'gene (Fig.  1). 
Transgenes were shown to be inserted into the mouse ge- 
nome in tandem, head-to-tail arrays with varying copy num- 
ber; no rearrangements or deletions of the transgenes were 
detected by Southern blot analysis (Fig.  1);  (Slack et al., 
1991). From these earlier studies we determined that trans- 
genes containing -2,300  bp of Y-flanking sequence were 
expressed in a highly tissue-specific, quantitatively correct 
manner, with maximum levels of expression in bone and tail 
and moderate levels in skin (Slack et al., 1991). The pattern 
of expression was similar, but not identical, to that seen with 
mCOL. Surprisingly, deletion of sequences within the first 
intron, between +292 and +1440, did not appear to affect 
the overall quantitative expression of constructs driven by 
2,300 bp of promoter. In contrast, transgenes driven by 444 
bp of promoter exhibited levels of expression that were 15- 
to 500-fold lower than those of  the endogenous gene, and ex- 
pression was not detected from transgenes driven by 444 bp 
of promoter and in which the intronic sequences had been 
deleted.  These observations indicated that the  -2300  to 
-444 region was necessary for full expression of the trans- 
gene; moreover, the first intron did not appear to be neces- 
sary when this region was present. 
In our previous studies, we did not distinguish among the 
cell types in the tissues that transcribed the hGH transgene. 
In addition, expression of mCOL varied significantly with 
the age of the animal. Although expression ofhGH was com- 
parable to that of mCOL in animals of similar age, the over- 
all variability and multicellular nature of the tissues did not 
permit a precise assessment of the expression of the trans- 
genes. To define more clearly the role of sequences between 
-2300 and +1607 in regulation of od(I) collagen gene ex- 
pression, we investigated the cell type-specific expression of 
the transgenes by in situ hybridization. 
Two mouse lines carrying -2300COL-hGH were studied 
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Figure 1. Schematic representation of human al(l) coilagen-hGH 
minigenes. These contructs were used for the generation of trans- 
genie mice and cell lines (designated by the four-digit number of 
the original founder, with the copy number per line as shown). 
-2300COL-hGH  contains approximately 2,300 bp of 5"flanking 
sequence and extends through most of the first intron, to +1607, 
of  the human al (1) collagen gene, designated  by the open rectangle. 
The cd(l) first exon is designated by the closed rectangle. The ar- 
row indicates the start of  transcription. The first intron of  the cd(I) 
gene is fused to the third intron of the hGH cassette, designated by 
the hatched rectangle. The polyadenylation signal (pA) and tran- 
scription termination region are provided by the hGH cassette. The 
restriction endonuclease recognition sites used for deletion con- 
structs, an EcoRV site at -444, BamI-II site at -2300, and SstII 
sites at +292 and +1440, are also shown. 
by in situ hybridization of sections from 17-d-old embryos. 
To compare expression of  the transgene to that of  the endoge- 
nous gene, we used riboprobes specific to the hGH minl"gene 
and to the mCOL 3' UTR, respectively. No hybridization 
with the hGH riboprobe was observed on sagittal sections of 
control,  nontransgenic  embryos  (data  not  shown).  The 
specificity of the mCOL dboprobe has been previously es- 
tablished (Slack et al.,  1991; Reed et al.,  1993).  It should 
be stressed that in all of the following studies hybridization 
with the mCOL riboprobe was used primarily as an internal 
reference to compare the level of expression of different 
transgenes in different tissues, rather than as a measure of 
the extent to which the expression of a transgene mimicked 
that of the endogenous gene.  Fig. 2  shows representative 
darkfield photomicrographs of sagittal sections of embryos 
from two separate lines of -2300COL-hGH mice, line 6231 
(Fig. 2, A-F) and line 8848 (Fig. 2, G-L), after in situ hy- 
bridization with mCOL (Fig. 2, A-C and G-I) or hGH (Fig. 
2, D-F and J-L) riboprobes. Fig. 2, A and G show a charac- 
teristic pattern of  endogenous mCOL expression: high levels 
in bone,  periosteum, perichondrium,  tendon, fascia, and 
dermis. A lower level of  mCOL was present in skeletal mus- 
cle, whereas no expression was observed in cartilage and 
epidermis. Serial sections hybridized with the riboprobe for 
hGH showed a similarly high level of  expression of the trans- 
gene in bone, periosteum, tendon, fascia, and dermis, with 
no expression in cartilage or epidermis (the apparent signal 
in the epidermis in Fig. 2, E was not reproducible and is a 
common artifact of this procedure). 
R was interesting that the transgene was not observed in 
skeletal muscle, a tissue in which the endogenous gene is 
clearly expressed. Furthermore, the transgene was also not 
detected in the perichondrium. A higher magnification  of  the 
periosteum/perichondrium (Fig.  2,  B  and E,  see  below) 
shows this differential expression more clearly. The endoge- 
Liska et al. Role of First lntron  in ¢x(l) Collagen Expression  697 Figure 2. Representative photomicrographs from 17-d-old  mouse embryos carrying the -2300COL-hGH transgene. Serial sagittal sections 
from line 6231 (A-F) and line 8848 (G-L) were hybridized with probes for either mCOL (A-C and G-I) or hGH (D-F and J-L). High 
magnification of skin sections are shown in B, C, E, E  H, L K, and L. A and D show a lower magnification of the pelvic region of line 
6231, and G and J  show a section through the thorax of line 8848. The arrows point to perichondrium,  b, bone;  c, cartilage; d, dermis; 
e, epidermis;f, fascia; m, skeletal muscle; pc, perichondrium; po, periosteum;  t, tendon. Bars:  (,4, D, G, and J) 150 #m; (B, C, E, E 
H, L K, and L) 30 um. 
nous  gene  was  expressed throughout  the  periosteum and 
perichondrium,  whereas  expression  of the  transgene  was 
limited to the osteogenic layer of the periosteum, to the ex- 
clusion of the perichondriurn. These data suggest that the se- 
quences necessary for direction of appropriate transcription 
of the cd(I) collagen gene to skeletal muscle and perichon- 
drium are not present between -2300 and +1607 of the hu- 
man gene. 
Transcript levels for both the transgene and the endoge- 
nous gene were similar in fibroblasts of the dermis and un- 
derlying connective tissue fascia. Higher magnifications of 
skin sections (Fig. 2 C) indicated that, in both lines of mice, 
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Skeletal 
Line  Bone  Tendon  Dermis  Fascia  muscle  Perichondrinm 
Endogenous 
o~I(I)COL 
- 2300COL - hGH 
-2300COL(AI)  -hGH 
4+  4+  3+  3+  2+  3+ 
~31  4+  4+  3+  3+  -  - 
8~8  4+  4+  3+  3+  -  - 
4072  4+  4+  ±  2+  -  - 
4082  4+  4+  ±  ±  -  - 
40~  4+  4+  -  1+  -  - 
Expression of ¢tl(1) endogenous collagen  and transgene mRNAs in 17-d-old  mouse embryos  was assessed by in situ hybridization  of 35S-labeled  mCOL  and hOH 
riboprobes. Degrees  of expression:  4- , weak; I+ to 4+, moderate  to strong; -, no expression  detected. 
fibroblasts throughout the dermis and connective tissue fas- 
cia expressed the transgene in a pattern similar to that of the 
endogenous gene. The transgene therefore apparently con- 
tains the cell-specific information necessary for expression 
of od(I) collagen by dermal and interstitial fibroblasts, as well 
as by tendon  fibroblasts,  osteoblasts,  and periosteal cells. 
These results are summarized in Table I. 
Sequences within the First lntron Are Required for 
Expression of COL-hGH Minigenes by Fibroblasts, but 
Not by Periosteal or Tendon Cells or by Osteoblasts 
Tissues from three lines of mice containing the transgene, 
-2300COL(AD-hGH, were examined by in situ hybridiza- 
tion of sagittal sections from 17-d-old embryos, concomi- 
tantly  with  tissues  from the  -2300COL-hGH  transgenic 
mice. Three separate experiments were performed, and sec- 
tions from at least two different embryos were analyzed for 
each line. Figs. 3 and 4  show representative darktield pho- 
tomicrographs of sagittal sections after hybridization with 
the riboprobe for either mCOL (Fig. 3, A-C; Fig. 4, A and 
B)  or hGH (Fig. 3, D--~ Fig. 4, C and D). As seen with the 
-2300COL-hGH  transgene,  high  levels  of signal  corre- 
sponding to the intron-deleted transgene were observed in 
tendon, bone and periosteum, whereas expression was not 
apparent in skeletal muscle or perichondrium (compare Fig. 
3, A and D; C and F; Fig. 4, A and C). The reduced expres- 
sion of the transgene in the fibrous layer of the periosteum, 
previously noted in Fig. 2, B  and E, was also observed in 
Fig.  3,  C  and E  However, in contrast to the  -2300COL- 
hGH transgene, the endogenous gene and the intron-deleted 
Figure 3. Representative photomicrographs  from 17-d-old mouse embryos carrying the -2300COL(AD-hGH transgenes.  Serial sagittal 
sections from line 4084 were hybridized with probes for either mCOL (A-C) or hGH (D-F). High magnification of skin sections are 
shown in B, C, E, and F. Lower magnification of the pelvic regions (A and D) are shown. The arrows point to tendon, b, bone; c, cartilage; 
d, dermis; e, epidermis;f, fascia; m, skeletal muscle; pc, perichondrium; po, periosteum.  Bars: (A and D) 150/tin;  (B, C, E, and F) 30/~m. 
Liska et al. Role of First  lntron in c~(1) Collagen  Expression  699 Figure 4. Representative  pho- 
tomicrographs from 17-d-old 
mouse embryos of line 4072 
carrying the -2300COL(AI)- 
hGH transgene. Serial sagittal 
sections were hybridized with 
probes for  either mCOL  (A 
and B) or hGH (C and D). 
High  magnifications of skin 
sections  are shown  in B and D. 
A lower magnification of the 
pelvic region (A and C) is also 
shown, b, bone; c, cartilage; 
d, dermis; e, epidermis;f, fas- 
cia;  pc,  perichondrium;  m, 
skeletal  muscle;  t,  tendon. 
Bars: (A and C) 150 ~tm; (B 
and D) 30 #m. 
transgene were differentially  expressed in the dermis and fas- 
cia. For example, comparison of sections of skin from line 
4084 (Fig. 3, A and D) indicated little expression in fascia 
and low expression in dermis of the -2300COL(AI)-hGH 
transgene. This difference in expression is more obvious in 
a section from dermis that is less compressed (Fig. 3, B and 
E).  In these areas, fibroblasts of the fascia clearly express 
the transgene, although at an apparently lower level than that 
of  the endogenous gene. In contrast, fibroblasts in the dermis 
show minimal expression ofthe transgene (Fig. 3 E). Similar 
results were obtained with sections from line 4082 (data not 
shown), but in this line expression in both dermis and fascia 
was low (Table I). 
In line 4ff72 the -2300COL(AI)-hGH transgene was ex- 
pressed in fascia at a relatively higher level than was the same 
transgene  in  lines  4082  and  4084.  Representative  pho- 
tomicrographs of skin from hip (Fig. 4, B and D) showed a 
similar level of expression of the transgene and endogenous 
gene in fihroblasts of the fascia, whereas dermal fibroblasts 
again displayed low expression of the transgene. Thus, data 
from  two  lines  of  -2300COL-hGH  and  three  lines  of 
-2300COL(AI)-hGH transgenic mice indicate that some of 
the sequences necessary for appropriate expression of the 
cd(1) collagen gene in dermal fibroblasts are located between 
+292 and +1440 (Table I). 
Support for differential expression of  the -2300COL(AD- 
hGH transgene in different tissues was obtained by RNase 
protection analyses of whole limb and skin from 17-d-old 
embryos (Table II). Although there was considerable vari- 
ability which can be attributed in part to small differences 
in age of embryos, the -2300COL-hGH and -2300COL- 
(AI)-hGH transgenes  were  expressed  at  similar levels in 
limb, and the -2300COL-hGH transgene was expressed at 
similar levels in limb and skin. However,  the -2300COL- 
(AI)-hGH transgene was expressed at a lower level in skin 
than in the whole limb (Table R). This difference was partic- 
ularly evident in lines 4082 and 4084 and was less apparent 
in line 4072, a finding which correlates with the relatively 
high level of  expression of  the intron-deleted transgene in the 
subdermal fascia of line 4072 (Table 1"). 
The ~rst Intron Is Required  for Expression of  the 
Transgene by Cultured Dermal l~Ibroblasts 
To clarify the conflicting results reported with various fibre- 
blast cell lines in vitro, we determined whether ceils derived 
from transgenic mice would express the transgene in a man- 
ner similar to that of the endogenous gene. Dermal fibre- 
blasts were obtained from primary cultures of skin explants 
from transgenic animals. Cells were determined to be fibro- 
blastic by morphology. Cultures in which cells exhibited 
characteristics of transformation, such as altered morphol- 
ogy, increased rate of proliferation and/or loss of relative 
contact inhibition, were excluded. After approximately three 
passages, RNA and DNA were obtained from the cells. RNA 
was analyzed for expression of both the hGH minigene and 
the endogenous mCOL gene by RNase protection assay. The 
results, presented as molecules of mCOL or hGH RNA per 
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Tissues of 1  7-d-old Embryonic Mice 
hGH Expression* 
Construct  Line  Limb  Skin 
-2300COL-hGH  3584  149 ±  83 (6)  89 ±  42 (6) 
6231  80 +  69 (3)  74 +  31 O) 
8848  190 ±  82 O)  160 ±  55 (3) 
-2300COL(AD-hGH  4072  132  ±  53 O)  43  +  22 (4) 
4082  24*  0.5*; 0.2 
4084  105,  6; 9 
*Values are reported as the mean +  SEM of molecules of hGH RNA (10  -7) 
per ~tg of tissue RNA. The number of analyses of independently derived sam- 
pies is shown in parentheses. 
fl"issues from two or three animals were pooled prior to analysis. 
microgram of total cellular RNA, were quantitated by com- 
parison with a  standard  curve prepared with  sense-strand 
RNA. Fig. 5 shows a representative RNase protection assay 
of hGH and mCOL. Fibroblasts obtained from the dermis 
of -2300COL(AD-hGH transgenic mice did not contain de- 
tectable RNA for the hGH transgene, whereas endogenous 
mCOL RNA was readily apparent (Fig. 5, lane 6). In con- 
Wast, hGH RNA was detected in dermal fibroblasts from mice 
that contained either the -2300COL-hGH or the -444COL- 
hGH transgene  (Fig.  5,  lanes 4  and 5).  Analysis of DNA 
from the same cells by dot-blot hybridization indicated that 
the lack of expression of the transgene in the absence of in- 
tronic sequences did not result from the loss of  the transgenic 
DNA during the culture process (data not shown). 
The results shown in Fig. 5 were reproducible when cells 
were obtained from animals of different ages as well as from 
all the lines that we tested (Table Ill). We observed that the 
transgene was expressed at lower levels than the endogenous 
mCOL gene in all cases;  we have also observed levels of 
Table IlL  Expression of Collagen-hGH Transgenes in 
Cultured Dermal Fibroblasts 
Expression* 
Ratio of 
Construct  Line  Age  hGH*  mCol  hGH/mCol 
-2300COL-hGH  3584  17 d  12  31  0.4 
24 me  4  18  0.24 
6231  17 d  4.2  24  0.18 
2 me  5  73  0.07 
8848  17 d  8  35  0.28 
1 me  1  11  0.1 
15 me  1.5  2.2  0.65 
-2300COLAI-hGH  4072  17 d  0  77  0 
4082  17 d  0  11  0 
13 me  0  11  0 
23 me  0  107  0. 
4084  17 d  0  3  0 
2 me  0  26  0 
24 me  0  12  0 
-444COL-hGH  5007A  17 d  7  13  0.11 
12 me  8  47  0.17 
5007B  17 d  3.3  28  0.12 
3 me  7  7  1.15 
12 me  2  3  0.73 
24 me  99  122  0.81 
*Values are reported as molecules of hGH or mCOL RNA (10  -~) per micro- 
gram of total cellular RNA. See text for details. 
fl'he presence of transgenic DNA was verified in all  17 d  cultured cells by 
dot-blot analysis. In addition, transgenic DNA was demonstrated in cultured 
cells from line 4084 (2 me) and line 4084 (24 me). 
transgene expression within an order of magnitude of that of 
the endogenous gene in tissue homogenates of adult and 17- 
d-old embryo bone and tail (data not shown;  Slack et al., 
1991).  Although the transcripts of both the hGH transgenes 
and the endogenous mCOL gene are relatively stable, they 
might differ in stability since they contain different 3' UTRs; 
this consideration,  and the effect of multiple copies of the 
transgene, preclude an accurate comparison of the levels of 
expression of the transgenes  with that  of the  endogenous 
gene. 
Figure 5. RNase protection assay comparing expression of human 
al(I) collagen-hGH  transgenes  and the endogenous mouse ,l(I) 
collagen gene in 17-d-old embryos (lanes 1-3) and in fibroblasts 
cultured from 17-d-old embryonic skin (lanes 4-6). Lanes I  and 
4;  -444COL-hGH line 5007A; lanes 2 and 5,  -2300COL-hGH 
line 3584; lanes 3 and 6,  -2300COL(AI)-hGH, line 4082.  Lanes 
1-3:10/~g of RNA was used for analysis OfhGH and 2 ~tg of RNA 
was analyzed for expression of endogenous ~l(I) collagen.  Lanes 
4-6:5/~g of RNA was analyzed for expression of hGH and 0.5/Lg 
of RNA was analyzed for endogenous cd(I) collagen (RNA). Lane 
7, expression of hGH as compared to expression of endogenous 
ctl(I) collagen  in  dermal fibroblasts  cultured  from a  2-me-old 
mouse from line 4084 containing the -2300COL(AD-hGH trans- 
gene; 8 #g and 3.5 #g Of RNA were used for analysis ofhGH and 
endogenous txl (1) collagen, respectively. All autoradiograms  were 
exposed for 4 h. 
Discussion 
Our laboratory is interested in the molecular mechanisms in- 
volved in the regulation of expression of the cd(I) collagen 
gene~ We have established that the  -2300COL-hGH trans- 
gene, which contains 2,300 bp of the promoter and the first 
intron  of the  human ¢xl(I) collagen gene driving  an hGH 
minigene, is expressed in most tissues of 17-d-old embryos 
that  express  the  endogenous  gene,  with  the  exception  of 
skeletal muscle and perichondrium (summarized in Table D. 
Transgenes  that  contain  a  deletion  of sequences  between 
+292 and  +1440 of the od(I) collagen first intron are also 
expressed by osteoblasts, tendon fibroblasts, and osteogenic 
cells. However, these transgenes are expressed poorly, or not 
at all, in dermal fibroblasts, both in vivo and in cell culture. 
These data indicate that the ~l(I) collagen gene utilizes mul- 
tiple and sometimes different DNA sequences to direct quan- 
titative and cell-specific expression. 
Type I collagen genes are transcribed in a  large number 
of tissues by most cell types of mesenchymal origin, but the 
levels of expression of type I collagen vary greatly. It is there- 
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rely on mechanisms that utilize cis-acfing sequences located 
in different regions of the gene and fJanking  DNA for the 
direction of tissue- and cell-specific expression.  Our study 
has identified at least three separate categories of cells in- 
volved in the cell-specific expression of od(I) collagen:  (a) 
osteoblasts, osteogenic cells, and tendon fibroblasts, which 
require 5"flanking sequences and do not rely on intronic se- 
quences; (b) fibrobiasts, which require sequences within the 
frst  intron  for  full  expression;  and  (c)  skeletal  muscle, 
perichondrial cells, and cells within the fibrous layer of the 
periosteum,  which require sequences either 5' or 3' to the 
-2300 to +1607 region of the human o~l(I) collagen gene, 
In addition, in our earlier studies, all the transgenes, includ- 
ing a -444COL(AI)-hGH transgene in which deletions had 
been made in both the 5"fla~king and intronic  sequences, 
continued to be expressed at levels that were comparable to 
that of the endogenous gene in lung (Slack et al., 1991). The 
latter findings indicate that some cell types may require only 
a minimal ~l(I) collagen promoter to direct appropriate ex- 
pression of the gene. 
The first suggestion that the od0) collagen gene was under 
differential, tissue-specific regulation was made from studies 
of Movl 3 mice, in which germline integration of a retrovirus 
into the first intron of the gene abolished transcription in all 
mesenchymal by derived cells except osteoblasts and odonto- 
blasts (Schnieke et al., 1983; Kratochwil et al., 1989; Schwarz 
et al., 1990). This finding indicated that fibroblasts required 
intronlc and/or other 3' sequences to be present in a spatially 
correct manner for expression of the cd(1) collagen gene. In 
support of this observation, an od(I)-CAT transgene, which 
contained only the promoter and 5'-flanking sequence of the 
rat od(I) collagen gene, was expressed at high levels in bone, 
teeth, and tendon, but showed little or no expression in skin 
(Pavlin et al.,  1992). Furthermore,  al(I) collagen-reporter 
gene constructs that included sequences from the first intron 
displayed a marked enhancement of expression over intron- 
deleted constructs  after transient  transfection  into  certain 
fibroblastic cells (Bornstein et al., 1988; Rippe et al., 1989; 
Boast et al., 1990; Liska et al., 1990,  1992). These observa- 
tions, taken together with the present study, indicate that the 
first intron is required for the fibroblast-specific expression 
of the cd(I) collagen gene. Intronic sequences could mediate 
transcription of this gene by two distinct, but not necessarily 
exclusive, mechanisms:  (a) cis-acting enhancer element(s) 
within the first intron might interact indirectly with promoter 
elements through specific DNA-binding proteins; or (b) se- 
quences within the first intron might be involved in the estab- 
lishment of a transcriptionally  active chromatin  conforma- 
tion at the gene locus. 
Only  a  few protein-DNA  binding  elements  have been 
characterized in the first intron of the ,l(I)  collagen gene: 
an APl-binding sequence that enhances transcription (Liska 
et al., 1990), and two tandem SPl-binding sequences (Liska 
et al.,  1992). Mutation of the AP1 element abolished both 
the specific protein-DNA binding activity and the enhance- 
ment observed by the first intron in transiently transfected fe- 
tal fibroblasts and stromal cells (Liska et al.,  1990), as well 
as  in  dedifferentiated  chondrocytes  (M[itt/i  et  al.,  1993). 
Since 27 of the 29 bases of the API element are identical in 
the rat and human alfl) collagen introns,  the AP1 element 
could play an important role in the regulation of ,l(I) celia- 
gen. The SPl-binding sequences are also conserved between 
the rat and human genes. However, site-directed mutagene- 
sis of the SPl-binding  sequences did not compromise the 
ability of the first intron to enhance transcription,  but it was 
associated with a modest increase in expression of collagen- 
reporter  gene  constructs  in  transient  transfection  assays 
(Liska et al.,  1992). These data indicate that the activity of 
the first intron,  observed in assays in vitro,  is mediated in 
part through the API element and support a model in which 
the AP1 element stimulates transcription by transactivation. 
In the second model we propose that sequences within the 
first intron might be involved in the formation of a transcrip- 
tionally active chrornatin conformation at the transcription 
start site. Although the two models are not mutually exclu- 
sive, the latter predicts that specific sequences within the first 
intron mediate nucleosome formation and, subsequently, ac- 
cessibility of the transcription complex to the transcriptional 
start site (reviewed by Felsenfeld, 1992). It is interesting that 
the SPl-binding sequences in the first intron reside within a 
DNase HS site (Barsh et al.,  1984); these elements might 
therefore function in the modulation of chromatin conforma- 
tion.  Since the lack of od(1) collagen gene transcription  in 
Movl3 mice is associated with the absence of a DNase HS 
site at the promoter of the gene (Breindi et al.,  1984), the 
first intron is likely to be involved in the establishment of an 
active chromatin  conformation.  However, in Mov13 mice, 
the od(I) collagen gene is transcriptionally  silent in all cells 
of mesenchymal origin except odontoblasts and osteoblasts. 
In our study, the deletion of sequences within the first intron 
inhibited expression of the transgene in dermal fibrobiasts 
and, to a lesser extent, in fibrobiasts of the fascia (Table I). 
It is possible that the low level of transgene expression ob- 
served in fascial fibroblasts was due to elements within the 
remaining  intronic  sequences  (between  +223  and  +291, 
and/or +1440 and +1607) which were not deleted from our 
constructs. 
While we favor one of the above models, or a combination 
of the two, we cannot completely exclude other explanations 
for the results we have observed in transgenic animals. Since 
the size of the splicable first intron differs in the intact and 
intron-deleted transgenes, it is possible that altered efficiency 
of splicing, with attendant consequences for efficient mRNA 
production,  could influence transgene expression.  The re- 
suits reported in Table 1I argue against such an effect in all 
tissues  since  the  -2300COL-hGH  and  -2300COL(AI)- 
hGH transgenes  were expressed at approximately  similar 
levels in tissues of the limb among the six lines that were 
studied. Although introns have been shown to facilitate the 
expression  of genes  in  transgenic  mice  (Brinster  et  al., 
1988), there was no obvious correlation between expression 
and intron length when a heterologous intron was placed be- 
tween  the  first  and  second  exerts  of an  intronless  gene 
(Palmiter et al.,  1991).  Indeed, introns of the approximate 
length of the first intron in  -2300COL(AI)-hGH  (260 bp) 
were effective in the study of Palmiter et al.  (1991) and are 
naturally spliced in many genes. 
In our study, deletion of intronic sequences did not alter 
expression  of the  transgenes  in  osteoblasts  or  in  tendon 
fibroblasts. Similarly, high levels of expression of a rat ,I(I)- 
CAT transgene,  in which a sequence from -3521 to  +115 
of the rat odfl) collagen gene was used as a promoter DNA, 
was observed in bone, developing tooth germ,  and tendon 
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have shown that a 624-bp region of the rat otl(I)  collagen 
gene,  located between  -2296  and  -1672,  is required  for 
high level expression of rat t~I(I)-CAT  constructs in intact 
bone. That the rat and human oil(I) collagen genes exhibit 
considerable spatial and sequence conservation in this region 
(J. L. Slack, personal communication) indicates that the se- 
quences necessary for high, osteoblast-specific expression of 
the human t~l(1) collagen gene might also lie in the 5' flanking 
region between -2300 to  -1600.  Consonant with this no- 
tion, in situ hybridization and qualitative RNase protection 
analyses showed that the -444COL-hGH transgene was ex- 
pressed at levels significantly lower than those observed with 
the -2300COL-hGH transgene in bone (Slack et al.,  1991; 
data not shown). However, the low level of expression of the 
-444COL-hGH transgene would predict that the basal txl(I) 
collagen promoter contains  some osteoblast-specific infor- 
marion. A thorough understanding of the cis-acfmg elements 
necessary  for osteoblast-specific gene expression  will  re- 
quire assessment of the ability of the -2300 to -1600 region 
to direct osteoblast-specific expression of constructs  con- 
taining  heterologous promoters. 
Our analyses of transgene expression in vivo, by in situ hy- 
bridi7ation,  and in cultured dermal fibroblasts from trans- 
genic animals clearly implicates c/s-acting sequences within 
the first intron of the od(l) collagen gene in the regulation of 
the gene in fibroblasts. We note that the effect of the intronic 
deletion was much more evident when transgene expression 
was assessed in dermal fibroblasts as opposed to fibroblasts 
of the fascia.  However, in at least two of the three intron- 
deleted transgenic  mouse lines,  transgene  expression was 
also compromised in fascial fibroblasts, in comparison to the 
expression of the endogenous gene. Several studies have in- 
dicated that fibroblasts of different tissues are heterogeneous 
in their reactivity, synthetic functions, and proliferative rate, 
although  they  are  morphologically  similar  (Harper  and 
Grove, 1978; Fleischmajer et al., 1981; ~  et al., 1988; 
Peltonen et al.,  1990). Consistent with these observations, 
our results indicate that the otl(I) collagen gene is regulated 
differently in fibroblasts of the dermis than in those of the fas- 
cia.  In  addition,  we found  that  some dermal  fibroblasts, 
specifically those closest to the fascia, did express the intron- 
deleted transgene. This difference is interesting since the hu- 
man  dermis  contains  two structurally  distinct  layers,  the 
papillary (upper) layer, and the reticular (lower) layer.  Dis- 
eases of the  skin rarely  affect both dermal  layers but are 
manifested  in  either  the  papillary  or  the  reticular  layer 
(Meigel et al.,  1977; Harper and Grove, 1978). A clarifica- 
tion of the mechanisms that regulate the fibroblast-specific 
expression of the r,l(I) collagen gene should further our un- 
derstanding of the distribution of pathology in dermatologi- 
cal disorders and may suggest ways in which to correct aber- 
rant collagen synthesis. 
In  the  final  analysis,  future  studies  of the  cell-specific 
regulation  of the od(I) collagen gene will have to be per- 
formed within the context of the endogenous gene in order 
to preserve the influence of chromatin conformation on gene 
expression. Targeted deletions and mutations of specific ele- 
ments in mice, by a double replacement homologous recom- 
bination  approach such as the "tag-and-exchange" strategy 
described by Askew et al. (1993), may be required to define 
unambiguously the mechanisms that govern cell-specific ex- 
pression of the od(I) collagen gene. Cell lines derived from 
such transgenic animals could also serve as useful models for 
investigation of the influence of collagen synthesis on the be- 
havior of dermal fibroblasts and other cells. 
We thank Victoria Robinson for assistance with the transgenic mouse lines 
and Dis. Jim Slack and Luisa lruela-Arispo for helpful discussions. 
This work was supported by grants AR 11248 and HL-03174 from the 
National Institutes of Health. D. J. Liska was supported by a grant from 
the American Heart Association, Washington Affiliate (92-WA-504), and 
M. J. Reed was supported by the Pfizer/American Geriatrics Society Fel- 
lowship Program. 
Received for publication 18 September 1993 and in revised form 21 Janu- 
ary  1994. 
References 
Adams, S. L. 1989. Collagen gene expression. Am. J. Respir. Cell Mol. Biol. 
1:161-168. 
Askew, G. R., T. Doetsclunan, and J. B. Lingrel. 1993. Site-directed  point mu- 
tations in embryonic stem cells: a gene targeting tag-and-exchange  strategy. 
biol.  Cell.  Biol.  13:4115-4124. 
Barsh, G. S., C. L. Roash, and R. E. Gelinas. 1984. DNA and chromatin struc- 
ture of the od(1) collagen gene. J. Biol.  Chem.  259:14906-14913. 
Boast, S., M.-W. Su, F. Ramirez, M. Sanchez, andE. V. Awedimento. 1990. 
Functional analysis of cis-acting DNA sequences  controlling transcription of 
the human type I collagen genes. J. Biol.  Chem.  265:13351-13356. 
Bornstein, P., and L McKay. 1988. The first intron of the etl(I) collagen gene 
contains several transcriptional regulatory elements. J.  Biol.  Chem.  263: 
1603-1606. 
Bornstein, P., and H.  Sage.  1989.  Regulation of collagen gene expression. 
Prog. Nucleic Acid Res. 37:67-106. 
Bornstein, P., J. McKay, D. J. Liska, S. Apone, and S. Devarayalu. 1988. In- 
teractions between the promoter and first intron are involved in transcrip- 
tional  control  of  cd(I)  collagen  gene  expression.  Mol.  Cell  Biol.  8: 
4851 --4857. 
Breindl, M., K. Harbers, and R. Jaenisch. 1984. Retrovirns-induced  lethal mu- 
tation in collagen I gene of mice is associated with an altered chrometin struc- 
ture. Cell.  38:9-16. 
Brenner, D. A., R. A. Rippe, and L. Veloz.  1989.  Analysis of the collagen 
otl(I)  promoter. Nucleic Acids Res.  17:6055-6064. 
Brinster, R.  L., J.  M.  Allen, R.  R.  Behringur, R.  E.  C,  elinas, and R.  D. 
Palmiter.  1988.  Introns increase transcriptional efficiency  in transgenic 
mice. Proc. Natl. Acad.  Sci.  USA.  85:836-840. 
Cheah, K. S. E., E. T. Lau, P. K. C. An, and P. P. L. Tam. 1991. Expression 
of the mouse c~101) collagen gene is not restricted to cartilage during devel- 
opment. Development (Camb.).  111:945-953. 
de Crombrugghe, B., T. Vuodo, G. Kaisenty, S. Malty, C. E. Rutheshouser, 
and H. Goldberg. 1991. Transcriptional control mechanisms  for the expres- 
sion of type I collagen genes. Ann. Rheum. Dis. 50:872-876. 
Diaz, A., E. Munoz, R. Johnston, J. H. Korn, and S. A. Jimenez. 1993. Regu- 
lation of human lung fibroblast  otl(I) procollagun gene expression by tumor 
necrosis factor ~x, interleukin-1/~,  and prostaglandin F_~. J.  Biol.  Chem. 
268:10364-10371. 
Felsenfeld, G. 1992. Chromatin as an essential part of the transcriptional mech- 
anism. Nature (land.).  355:219-223. 
Fleischmajer, R., J. S. Perlish, T. Krieg, and R. Timpl. 1981.  Variability in 
collagen and fibronectin synthesis  by scleroderma fibroblasts in primary cul- 
ture. d.  Invest.  Derm. 76:400-403. 
Harbers, K., M. Kuehn, H. Delins, and R. Jaenisch. 1984. Insertion of retrovi- 
rus into the first intron of ¢xl (I) collagen gene leads to embryonic lethal muta- 
tion in mice. Proc. Natl. Acad. Sci.  USA.  81:1504-1508. 
Harper, R. A., and G. Grove. 1978. Human skin fibroblasts derived from papil- 
lary and reticular dermis: differences in growth potential in vitro. Science 
(Wash.  DC). 204:526-527. 
Harrison, J. R., S. J. Vargas, D. N. Peteisen, J. A. Lorenzo, and B. E. Kream. 
1990.  Interleukin-lr, and phorbol ester inhibit collagen synthesis in osteo- 
blastic MC3T3-E1 cells by a transcriptional mechanism. Mol.  Endocrinol. 
4:184-190. 
K~hari, V.-M., M. Sandberg, H. Kalimo, T. Vuorio, and E. Vuorio.  1988. 
Identification  of fibroblasts responsible for increased collagen production in 
localized scleroderma by in situ hybridization. J. Invest. Derm. 90:664-670. 
Kaisenty, G., P. Golumbek, and B. de Crombrugghe. 1988.  Point mutations 
and small substitution mutations in three different upstream elements inhibit 
the  activity  of  the  mouse  t~2(I) collagen  promoter.  Y.  Biol.  Chem. 
263:13909-13915. 
Kratochwfl, K., K. yon der Mark, E. J. Kollar, R. Jaenisch, K. Mooslehner, 
M.  Schwarz,  K.  Haase, I.  Gmachl, and K.  Harbers.  1989.  Retrovirus- 
induced insertional mutation in Movl3 mice affects collagen I expression in 
Liska et al. Role of First Intron in ct(I) Collagen  Expression  703 a tissue-specific  manner. Cell. 57:807-816. 
Krebshach, P. H., J. R. Harrison, A. C. Lichtler, C. O. Woody, D. W. Rowe, 
and B. E. Kream. 1993. Transgenic  expression of COL1Al-chloramphen- 
icol acetyltransferase  fusion genes in bone: differential utilization  of pro- 
motet elements  in vivo and in cultured cells. Mol. Cell. Biol. 13:5168-5174. 
Lisha, D. J., J. L. Slack, and P. Bornstein.  1990. A highly conserved intronic 
sequence is involved in transcriptional  regulation of  the cd (I) collagen gene. 
Cell ReguL 1:487--498. 
Liska, D. J., V. R. Robinson, and P. Bornstein.  1992. Elements in the first in- 
tron of  the al(1) collagen gene interact with Spl to regulate gene expression. 
C-ene Expression.  2:379-389. 
M~ttli, A., V. Glumoff, P. PAAkkonen,  D. I. Liska, R. P. K. Penttinen, and 
K. Elima.  1993. Nuclear factor binding to an AP-1 site is associated  with 
the activation of pro~l(1) collagen gene in dedifferentiating  cbondrocytes. 
Biochem. J.  294:365-371. 
Meigel, W. N., S. Gay, and L. Weber. 1977. Dermal architecture and collagen 
type distribution.  Arch.  Dermatol.  Res. 259:1-10. 
Niederreither,  K., R. N. D'Souza,  and B. de Crombrugghe. 1992. Minimal 
DNA  sequences that control the cell  lineage-specific  expression of the 
pro~2(I) coilagenpromotcrintransgenic  mice.J. CelIBiol.  119:1361-1370. 
Olsen, A. S., A. E. Geddis, and D. J. Prockop. 1991. High levels of  expression 
of a minigene version of the human prowl(I) collagen gene in stably trans- 
fected mouse fibroblasts.  J.  Biol. Owm. 266:1117-1121. 
Palmiter, R. D., E. P. Sandgren, M. R. Avarbock, D. D. Allen, andR. L. Brin- 
ster. 1991. Heterologous  introns can enhance expression of transgenes in 
mice.  Proc. Natl. Acad.  Sci. USA. 88:478-482. 
Pavlin, D., A. C. Lichller, A. Bedalov,  B. E. Kream, J. R. Harrison, H. F. 
Thomas, G. A. Gronowicz, S. H. Clark, C. O. Woody, and D. W. Rowe. 
1992. Differential u  "tflization  of regulatory domains within the ¢1(I) collagen 
promoter in osseous and fibroblastic  cells. J.  Cell Biol. 116:227-236. 
Peltonen, J., L. Kih~ri,  S. Jaakkola,  V.-M. Ifddt~, J. Varga, J. Uitto,  and 
S. A. Jimenez. 1990. Evaluation of transforming growth factor fl and type 
I  procollagen gene expression in fibrotic skin diseases by in situ hybridiza- 
tion. J.  Invest. Derrnatol. 94:365-371. 
Penttinan, R. P., S. Kobayashi,  and P. Bornstein.  1988. Transforming growth 
factor B increases mRNA for matrix proteins both in the presence and in the 
absence of changes in  mRNA  stahility.  Proc.  Natl.  Acad.  Sci. USA. 
85:1105-1108. 
Reed, M. J., P. Puolakkainen,  T. F. Lane, D. Dickerson,  P. Bomstein, and 
E. H. Sage.  1993. Differential expression of SPARC and thrombospondin 
1  in  wound  repair:  immunoloealization  and  in  sire  hybridization.  J. 
Histochem.  C~ochem.  41:1467-1477. 
Rippe, R. A., S.-I. Lorenzeu, D. A. Brenner, and M. Breindl.  19891 Regula- 
tory elements in the 5'-flAnkin~  iL~ion and the first intron contribute to tran- 
scriptional control of the mouse alpha 1 type I collagen gene. Mol. Cell Biol. 
9:2224-2227. 
Sandberg, M., and E. "v~orio. 1987. Localization of types I, II, and HI collagen 
mRNAs in developing human skeletal tissues by in situ hybridization. J. Cell 
Biol.  104:1077-1084. 
Schneike, A., K. Harhars,  and R. Jaenisch.  1983. Embryonic lethal mutation 
in mice induced by retrovirus insertion into the cd(I) collagen gene. Nature 
(Loud.). 304:315-320. 
Schwarz, M., K. Harbers,  and K. Kratochwil.  1990. Transcription  of mutant 
collagen I gene is a cell type and stage-specific marker for odontoblast and 
osteoblast differentintion. Deve/opment  (Camb.).  108:717-726. 
Slack, J. L., D. J. Liska, and P. Bornstein.  1991. An upstream regulatory region 
mediates high-level,  tissue-specific  expression of the human odfl) collagen 
gene in transgenic  mice. Mol. Cell Biol. 11:2066-2074. 
Slack, J. L., D. J. Liska, and P. Bornstein.  1993. Regulation of expression of 
the type I collagen genes. Am. J. Med. Genet. 45:140-151. 
The Journal  of Cell Biology,  Volume 125, 1994  704 